צמיחת רווח למניה משנה לשנה בשנים עשר החודשים האחרונים senestech.com (SNES)

The foundation of growth for SenesTech, Inc. (SNES) is high margins driven by its patent for non-lethal rodent control. The quarterly EPS beat confirms this trend, where 59.80 determines the current value of the metric. Expansion relies on the ban of toxic poisons in the agricultural sector. A further advantage is provided by the monopoly on ContraPest, which grants access to large government contracts and shields the company from price wars.

This metric calculates the dynamics of net profit per share on a quarterly basis with daily data interpolation, allowing for a quantitative assessment of the business monetization rate. For SenesTech, Inc. (SNES), expanding demand for eco-friendly biologicals in the agricultural sector directly impacts profitability; therefore, the quarterly EPS growth assessment serves as an indicator of the company's effectiveness in capturing this growing market.